Innovative Digital Platform Chrono Therapeutics' proprietary Digital Patch platform offers a unique transdermal drug delivery combined with personalized digital support, creating opportunities toMarket this integrated approach to healthcare providers and pharmaceutical companies seeking advanced treatment solutions for neurological and addiction-related conditions.

Expanding Program Pipeline With active development in therapies for smoking cessation, Parkinson's disease, and opioid dependence, the company presents multiple opportunities to partner on or supply innovative drug delivery devices and digital health solutions targeting these high-demand neurological markets.

Focus on High-Impact Indications Targeting underserved markets with unmet needs such as CNS disorders and addiction, Chrono Therapeutics' solutions are well-positioned for collaborations with clinics and healthcare systems aiming to improve compliance and outcomes for challenging-to-treat populations.

Sensor-Enabled Technology The development of sensor-enabled patches with connected apps opens possibilities for partnerships with tech firms and medtech companies looking to incorporate wearable digital health monitoring into their product portfolios or clinical integration strategies.

Strategic Funding and Growth With recent funding of $80 million and a focus on advancing innovative digital therapeutics, there are opportunities for investors or corporate partners to support scaling manufacturing, expanding clinical trials, or entering new therapeutic areas within the company's innovation roadmap.